Publications Database

Anderson L. T. et al. (1989)

The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children.

Journal of Autism and Developmental Disorders

19(2), pp. 227-239

Read Abstract (New Window)

Angley M. T. et al. (2007)

Children and autism: Part 1 - recognition and pharmacological management.

Australian Family Physician

36(9), pp. 741-744

Read Abstract (New Window)

Aoki Y. et al. (2014)

Oxytocin improves behavioural and neural deficits in inferring others' social emotions in autism.

Brain

November, 137(11), pp. 3073-3086.

Read Abstract (New Window)

Arehart-Treichel J. (2010)

Autism treatment arsenal expands, with more options on horizon.

Psychiatric News

45(10), pp. 20

Read Full (New Window)

Armenteros J. et al. (1995)

Haloperidol-related dyskinesias and pre- and perinatal complications in autistic children.

Psychopharmacology Bulletin

31(2), pp. 363-369

Read Abstract (New Window)

Arnold L. E. et al.

A 1.5-year follow-up of parent training and atomoxetine for attention-deficit hyperactivity disorder symptoms and noncompliant-disruptive behavior in autism.

Journal of Child and Adolescent Psychopharmacology

Read Abstract (New Window)

Arnold L. E. et al. (2000)

Assessment in multisite randomized clinical trials of patients with autistic disorder: the Autism RUPP Network.

Journal of Autism and Developmental Disorders

April, 30(2), pp. 99–111

Read Abstract (New Window)

Arnold L. E. et al. (2006)

Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial.

Journal of the American Academy of Child and Adolescent Psychiatry

45(10), pp. 1196-1205

Read Abstract (New Window)

Arnold L. E. et al. (2003)

Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials.

Journal of the American Academy of Child and Adolescent Psychiatry

42(12), pp. 1443-1450

Read Abstract (New Window)

Arnold L. E. et al. (2012)

Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders.

Journal of Child and Adolescent Psychopharmacology

22(3), pp. 198-205.

Read Abstract (New Window)

Arnold L. E. et al. (2012)

Research Units of Pediatric Psychopharmacology (RUPP) Autism Network randomized clinical trial of parent training and medication: One-year follow-up.

Journal of the American Academy of Child and Adolescent Psychiatry

51(11), pp. 1173-1184.

Read Abstract (New Window) Read Full (New Window)

Arora M. et al. (2011)

Asperger disorder in adults.

Southern Medical Journal

104(4), pp. 264-268

Read Abstract (New Window)

Asadabadi M. et al. (2013)

Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.

Psychopharmacology (Berl)

225(1), pp. 51-59.

Read Abstract (New Window)

Awad G. A. (1996)

The use of selective serotonin reuptake inhibitors in young children with pervasive developmental disorders: some clinical observations.

Canadian Journal of Psychiatry

August, 41(6), pp. 361-366

Read Abstract (New Window)

Ayyash H. F. et al. (2015)

Melatonin for sleep disturbance in children with neurodevelopmental disorders: prospective observational naturalistic study.

Expert Review of Neurotherapeutics

June, 15(6), pp. 711-717.

Read Abstract (New Window)

Bölte S. (2014)

Is autism curable?

Developmental Medicine and Child Neurology

October, 56(10), pp. 927-931.

Read Abstract (New Window)

Bachmann C. J. et al. (2013)

Psychopharmacological treatment in children and adolescents with autism spectrum disorders in Germany.

Research in Developmental Disabilities

June, 34(9), pp. 2551-2563.

Read Abstract (New Window)

Baribeau D. A. , Anagnostou E. (2014)

An update on medication management of behavioral disorders in autism.

Current Psychiatry Reports

16(3), pp. 437

Read Abstract (New Window)

Baribeau D. A. , Anagnostou E. (2014)

Social communication is an emerging target for pharmacotherapy in autism spectrum disorder: A review of the literature on potential agents.

Journal of Canadian Academic Child Adolescent Psychiatry

23(1), pp. 20-30.

Read Abstract (New Window) Read Full (New Window)

Barnard A. L. et al. (2002)

A systematic review of the use of atypical antipsychotics in autism.

Journal of Psychopharmacology

16(1), pp. 93-101

Read Abstract (New Window)